The ROE (Return on Equity) of Eiger BioPharmaceuticals Inc (EIGR) is -175.01%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2022-12-31 | -175.01% |
| 2021-12-31 | -46.85% |
| 2020-12-31 | -68.47% |
| 2019-12-31 | -124.34% |
| 2018-12-31 | -78.66% |
| 2017-12-31 | -188.67% |
| 2016-12-31 | -115.70% |
| 2015-12-31 | 256.15% |
| 2014-12-31 | -2.11% |
| 2013-12-31 | -136.99% |